Taiwan FDA registration 6f788616c420f5b1dcb09fcff76f7058

Vitex biochemical products directly glycoglobin reagents

TW: 維特司生化產品直接醣化血色素試劑

Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC·Registered Feb 12, 2007 – Feb 12, 2022Cancelled

Registration details

Analysis ID: 6f788616c420f5b1dcb09fcff76f7058
Customs Code: DHA00601791103

Company information

Manufacturer: ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC
Manufacturer Country: United States
Authorized Representative: DKSH TAIWAN LTD.

Product details

Intended Use: Quantitatively determine the concentration of heme and glycoglobin in the human blood to calculate the percentage of glycoglobin.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.7470 Analysis of glycosylated hemoglobin
Import Information: import

Dates and status

Registration Date: Feb 12, 2007
Expiry Date: Feb 12, 2022
Cancellation Date: Apr 12, 2024

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Vitex biochemical products directly glycoglobin reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6f788616c420f5b1dcb09fcff76f7058 and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.